Why the study?
Does Angiotensin-(1-7) improve vascular reactivity and inflammatory markers in a rat model of adjuvant-induced arthritis?
Does Angiotensin-(1-7) improve vascular reactivity and inflammatory markers in a rat model of adjuvant-induced arthritis?
Angiotensin-(1-7) improves endothelial dysfunction and reduces inflammatory markers in a rat model of rheumatoid arthritis, suggesting potential therapeutic value for arthritis-associated vascular disease.
Should not yet change practice in rheumatoid arthritis; leaves open whether Ang-(1-7) benefits translate to human vascular disease.
Altered vascular reactivity due to endothelial dysfunction, consequent to vascular damage, is observed in rheumatoid arthritis. We investigated the effect of angiotensin (Ang)-(1-7) on vasculature changes in arthritis induced by complete Freund's adjuvant in male Wistar rats. Arthritis decreased soluble receptor for advanced glycation end products (sRAGE) whereas elevated aortic RAGE expression, increased interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), systolic blood pressure and the contractility induced by phenylephrine and KCl. Moreover, arthritis decreased the relaxing effect of acetylcholine. Neither arthritis nor Ang-(1-7) altered sodium nitroprusside relaxation. Ang-(1-7) reversed the effect of arthritis on TNF-α, sRAGE and RAGE expression without any effect on the IL-1β. Ang-(1-7) decreased phenylephrine and KCl contractility, especially in the endothelial-denuded aorta, whereas increased acetylcholine relaxation in the endothelial-intact aorta. Ang-(1-7) could find its place in the treatment protocol of arthritis and vascular diseases.
No takes yet. Share an insight, caveat, or question.
Açikalin et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: